A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab - Concepedia

Concepedia

Publication | Closed Access

A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab

27

Citations

17

References

2022

Year

Dino Tarabar, Katia El Jurdi, Cindy Traboulsi, Olivia Yvellez, Zoran Milenković, Stanko Petrović, Bojana Subotić, Ann Gils, Tanja Brocic, Irina Brcerevic,

Inflammatory Bowel Diseases

Abstract

Bridging cyclosporine to vedolizumab in severe, steroid-refractory UC patients is effective and safe at inducing and maintaining clinical, endoscopic, and biochemical response and remission up to 52 weeks of follow-up. Larger prospective studies are warranted.

References

	Year	Citations

Page 1